Nathan Etessami

Nathan Etessami is a seasoned professional in the pharmaceutical industry with extensive experience in product planning and marketing. Currently, Nathan serves as the Sr. Director of New Product Planning at Cerevel Therapeutics since August 2022. Prior to this role, Nathan held multiple positions at Pfizer from April 2014 to August 2022, including Global Marketing Launch Director for the Meningococcal Franchise and several director-level roles within Inflammation & Immunology. Nathan's career also includes experience at The Boston Consulting Group as a Project Leader and Consultant, along with an MBA internship at Genentech focusing on Pipeline and Portfolio Planning. Nathan's educational credentials include an MBA in Health Care Management from The Wharton School and a BSE in Chemical Engineering from Princeton University.